Department of Medicine

University of Pittsburgh

Mark Anthony Socinski, MD


Professor of Medicine and Cardiothoracic Surgery

Director, Lung Cancer Section, Division of Hematology/Oncology

Clinical Associate Director, Lung SPORE

Co-Director, UPMC Lung Cancer Center of Excellence

Co-Leader, UPCI Lung Cancer Program

Office: 5150 Centre Avenue
Fifth Floor, Room 556
Pittsburgh, PA 15232
Phone: 412-648-6578
Fax: 412-648-6579
Find A Doctor UPMC Profile

B.A., University of Vermont, 1979
M.S., University of Vermont, 1983
M.D., University of Vermont, 1984

Internship in Internal Medicine, Harvard Medical School, 1985
Residency in Internal Medicine, Harvard Medical School, 1986
Fellowship in Medical Oncology, Dana-Farber Cancer Institute, 1989
Clinical Fellowship in Medicine, Harvard Medical School, 1989

Area of Specialization/Research Interest  
Thoracic oncology
Lung cancer
Clinical trials

Mark A. Socinski, MD, is a professor of medicine and cardiothoracic surgery at the University of Pittsburgh School of Medicine, and serves as director of the Lung Cancer Section at the University of Pittsburgh Cancer Institute, clinical associate director of the Lung SPORE, and co-director of UPMC Lung Cancer Center of Excellence, and co-director of the Lung and Thoracic Malignancies Program. Dr. Socinski specializes in all thoracic malignancies, including small cell and non-small cell lung cancers and mesothelioma. Dr. Socinski is board-certified in internal medicine and medical oncology. He received an undergraduate degree and a medical degree at the University of Vermont in Burlington, VT. He completed a residency in internal medicine at Harvard Medical School in Boston and a fellowship in medical oncology at Dana-Farber Cancer Institute in Boston. Dr. Socinski holds memberships in numerous professional societies such as the American College of Physicians, American Society of Clinical Oncology, International Association for the Study of Lung Cancer, and the American College of Chest Physicians. Dr. Socinski serves as co-Chair of the Thoracic Malignancies Steering Committee for the National Cancer Institute. Dr. Socinski’s primary research interests reside in all aspects of clinical trials related to the thoracic oncology population. He also serves on the Respiratory Core Committee of the Cancer and Leukemia Group B (Alliance) and has been instrumental in the development of many cooperative group trials.

For Pub Med search results, click here.